MULTIPLE SCLEROSIS, RELAPSING-REMITTING

Clinical trials for MULTIPLE SCLEROSIS, RELAPSING-REMITTING explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE SCLEROSIS, RELAPSING-REMITTING trials appear

Sign up with your email to follow new studies for MULTIPLE SCLEROSIS, RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 3 Not yet finished but already full! 7 Completed 4 Terminated 1

New MS injection trial aims to halt brain damage

Disease control Terminated

This study tested a version of an existing MS drug, natalizumab, given as a shot under the skin every four weeks. It aimed to see if this new method of delivery could effectively reduce new brain lesions and relapses in Japanese adults with relapsing-remitting MS. The trial also …

Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING

Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control

Last updated Feb 10, 2026 13:55 UTC

MULTIPLE SCLEROSIS, RELAPSING-REMITTING

Get alerted when new MULTIPLE SCLEROSIS, RELAPSING-REMITTING trials appear

New MS injection trial aims to halt brain damage